Home/Filings/4/0001437749-19-018985
4//SEC Filing

Gagnon Suzanne 4

Accession 0001437749-19-018985

CIK 0001029125other

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 5:35 PM ET

Size

7.3 KB

Accession

0001437749-19-018985

Insider Transaction Report

Form 4
Period: 2019-09-20
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
  • Purchase

    Common Stock

    2019-09-20+7,1428,142 total(indirect: By Trust)
  • Purchase

    Warrants (right to buy)

    2019-09-20+7,1427,142 total(indirect: By Trust)
    Exercise: $4.00From: 2019-09-20Exp: 2024-09-20Common Stock (7,142 underlying)
Holdings
  • Common Stock

    43,000
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $3.50 per "unit."

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001652855

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 5:35 PM ET
Size
7.3 KB